Navigation Links
Rigel Announces First Quarter 2012 Financial Results
Date:5/1/2012

coid lupus in the next few months," said James M. Gower, chairman and chief executive officer of Rigel.

About Rigel (www.rigel.com)

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include: fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with Rigel's collaboration partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's future product candidate pipeline and strategy, the potential uses and efficacy of Rigel's product candidates, the progress of Rigel's product development programs, including the timing of commencement and results thereof, the timing and design of its future clinical trials and potential milestones and regulatory filings associated with Rigel's product candidates, Rigel's corporate collaborations, and revenues that may be received from collaborations and the timing of those potential payments, and the future expected amount and sufficiency of Rigel's cash resources. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as  "plan," "expect,"
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today ... the Southern District of West Virginia ... for a single trial to take place on November ... include claims from the women plaintiffs that they were ... Ethicon subsidiary. The cases against Ethicon are among approximately ...
(Date:7/1/2015)... July 1, 2015 The Coalition of ... state and regional professional rheumatology societies, today released ... that explored perceptions of biosimilars and the potential ... Biosimilars are medicines that are highly ... are notably different from generic medications in that ...
(Date:7/1/2015)... Colo. , July 1, 2015   ... in implantable hearing solutions, announced today the US ... Cochlear™ Nucleus® Profile™ Implant with Slim Straight Electrode ... and developed in close collaboration with the world,s ... cochlear implant platform designed to provide the most ...
Breaking Medicine Technology:Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3
(Date:7/2/2015)... OR (PRWEB) , ... July 02, 2015 , ... Hand ... During the current summer flu season, according to fresh water advocate and radio host ... on the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied ...
(Date:7/2/2015)... LENEXA, Kan. (PRWEB) , ... July 02, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... One of the top executive search firms in the healthcare industry, B. E. ...
(Date:7/2/2015)... ... ... Throughout the month of April, Casey’s General Stores invited customers to give ... 7, Casey’s General Stores Chairman and CEO, Bob Myers, will present a check to ... nonprofit dedicated to restoring a sense of self, restoring the family unit, and restoring ...
(Date:7/2/2015)... ... 2015 , ... AvePoint Public Sector, Inc., a wholly owned subsidiary ... today announced it was named the recipient of the 2015 GTRA ConVurge Tech Award ... by the Government Technology Research Alliance (GTRA), was presented June 29 during the ConVurge ...
(Date:7/2/2015)... ... July 02, 2015 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it has made two ... is the new General Manager at Catalent’s Schorndorf facility, which provides large scale, ...
Breaking Medicine News(10 mins):Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2
... people with skin care information from their most ... insights are provided by skin care experts with ... The content is written by experts in skin ... advice. Key portions of the service include information ...
... Slimband employees successfully competed in the 19th Annual Canada Life CN Tower Climb ... ... 22, 2009-- A team of Slimband employees successfully competed in the ... April 16th. The CN Tower Climb is a demanding competition in which ...
... continues to follow her treacherous sister Notre Dame ... 22 Georgetown University continues to follow ... with award, pro-lifers to protest.On Wednesday, April 22, starting ... will protest at Georgetown Law Center, McDonough Hall, 600 ...
... 21 When Gundersen Lutheran Health System set out to ... 2 percent decrease that,s common at healthcare facilities. Instead, they,re ... than two years. That,s 9,600 metric tons of carbon dioxide ... of removing 1,631 cars from the road. The La Crosse, ...
... OKLAHOMA CITY, April 21 Costs to families and ... to the neighborhood gas station. That is why it ... affordable and accessible to all Oklahomans. Holding down the ... task, but controlling costs is a challenge we can ...
... Pharmos Corporation (Pink Sheets: PARS) announced today that ... and warrants. At the closing, the Company issued ... an additional 18,000,000 shares of common stock for an ... of the warrants, which have a five-year term, is ...
Cached Medicine News:Health News:Beauty-Doctors Website Provides Dermatologist-Authored Skin Care Information from Experts 2Health News:Slimband™ Team Competes in CN Tower Climb and Helps Fight Against Global Warming 2Health News:Anti Abortion Protesters will be at VP Biden Award at Georgetown Law School 2Health News:Innovative Program Will Help Lead Health System to Energy Independence by 2014 2Health News:Refuting Misconceptions About Health Insurance Mandates 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 3
... The ODEI750D cameras are a new generation of ... between digital and video imaging. Images are captured ... in both video and digital formats. Video signals ... images are sent to the PC as uncompressed ...
Bench Top Horizontal (clean bench) Airflow Cabinet...
... biocompatibility testing at various temperatures, this ... through a clean heating unit to ... to 140F. Transparent panels allow full ... easy access to the work area. ...
... hood ventilates and purifies hazardous chemical ... exhaust. Bonded charcoal filters remove most ... clearance (with access shield open) accommodates ... options include final HEPA filter, work ...
Medicine Products: